Growth in its breast health, diagnostics, and surgical gynecology businesses contributed to a 4% revenue gain for women's healthcare vendor Hologic in its fiscal second quarter.
For the period (end-March 27), the Bedford, MA-based vendor posted $418.1 million in revenue, up 4% compared to the $402 million recorded in the fiscal second quarter of 2009. Hologic had net income of $20.6 million, compared with a net loss of $2.31 billion a year ago.
In quarterly highlights, Hologic turned in a strong bookings quarter for international sales of its digital mammography systems, said Rob Cascella, president and CEO. The firm's breast biopsy, diagnostics, and surgical gynecology businesses also experienced growth, despite challenges stemming from the lagging effects of unemployment, healthcare policy uncertainties, and severe weather conditions, according to Cascella.
In the U.S., some customer order deferrals that affected backlog at the end of the second quarter have already been turned into orders in the third quarter, Cascella said.
Related Reading
Hologic debuts upright biopsy at ECR, March 8, 2010
Hologic, Ethicon bury the hatchet, February 22, 2010
Poor economy hits Hologic's Q1 numbers, February 2, 2010
Hologic targets cervical cancer screening, January 12, 2010
Hologic to unveil multimodality SecurView release, November 26, 2009
Copyright © 2010 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
